ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - glucagon as hydrochloride - אבקה וממס להכנת תמיסה להזרקה - glucagon as hydrochloride 1 mg - glucagon - glucagon - treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.

ישראל - עברית - Ministry of Health

megapharm ltd - glutamine - אבקה - glutamine 5 g/sachet - amino acids

ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - glucagon - אבקה - glucagon 3 mg

ישראל - עברית - Ministry of Health

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride - glutamic acid hydrochloride - dipeptiven is indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen.in patients in extreme cases of hypercatabolic stage such as major abdominal surgery, bmt, diffuse injury of gi mucous.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - arginine; aspartic acid; disodium phosphate dodecahydrate; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; magnesium chloride hexahydrate; methionine; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; glycine 12.00 g/l; l- alanine 10.50 g/l; proline 5.50 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; potassium acetate 2.453 g/l; sodium acetate trihydrate 2.858 g/l; magnesium chloride hexahydrate 0.508 g/l; lysine as acetate 8.56 g/l; disodium phosphate dodecahydrate 3.581 g/l - combinations

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - arginine; aspartic acid; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; lysine as monohydrate; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; l- alanine 10.50 g/l; glycine 12.00 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; proline 5.50 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; lysine as acetate 5.74 g/l; lysine as monohydrate 3.12 g/l - combinations

ישראל - עברית - Ministry of Health

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride

ישראל - עברית - Ministry of Health

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride

ישראל - עברית - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

ישראל - עברית - Ministry of Health

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.